Cary J. Reich

Part of Amring Pharmaceuticals, Inc., Visant Medical, Inc. is a clinical-stage medical device company based in Menlo Park, CA. Symatese SAS, a French company based in Lyon, was instrumental in the development of Lacrifill, significantly enhancing the product's design and performance, by leveraging its expertise in tissue regeneration, reconstruction, and related delivery systems. The company received FDA 510 (k) clearance in 2022 for Lacrifill® cross-linked hyaluronic acid-based canalicular occlusive device, which is intended to block tear drainage by occlusion of the canalicular system. The device is indicated for use, for up to 6 months, in patients experiencing dry eye symptoms. The company specializes in injectable crosslinked HA gels for many markets, including aesthetic, rheumatology, and ophthalmology. Symatese designs the most advanced medical device solutions thanks to their technology portfolio in hyaluronic acid, collagen, thermoplastics, and silicone. The company was founded by Cary J. Reich and Vartan E. Ghazarossian. Vartan E. Ghazarossian has been the CEO since incorporation. Visant Medical was acquired by Amring Pharmaceuticals, Inc. on December 18, 2023.

Inamed Corp. developed and manufactured breast implants, wrinkle prevention & obesity solutions. Its products were available through its two business divisions: INAMED Aesthetics, and INAMED Health. The company offered breast implants for augmentation, reconstruction surgeries, invasive surgeries for sustained weight loss and other dermal products to correct facial wrinkles. INAMED was headquartered in Santa Barbara, CA.

ForSight VISION5, Inc. develops ocular drug delivery technologies and device solutions for ophthalmic diseases. It engages in the development of non-invasive products to replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. Its lead product candidate is the Helios insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to continually receive their medication. The company was founded by Eugene de Juan Jr., J. Andrew Corley and K. Angela Macfarlane in 2010 and is headquartered in Madison, NJ.

Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL.

ForSight Labs LLC operates as an ophthalmic technology incubator. It focuses on developing and applying solutions to improve the sight, care, and quality of life of visually impaired patients. The company was founded by Eugene de Juan, Hanson S. Gifford and Henry A. Plain in 2005 and is headquartered in Menlo Park, CA.

Fusion Medical Technologies, Inc. is used to develop, manufactures and market surgical hemostatic products like sutures and topical agents such as sponges which are used to stop bleeding in a variety of surgeries. The Company's product floSeal (R) matrix hemostatic sealant was used to control surgical bleeding. It products were used in a variety of surgical procedures like cardiac, vascular, spinal, ear, nose, throat, head, neck and cranial surgeries. The company marketed its products through direct sales force. It was headquartered in Fremont, CA.